Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial

SU Abdullahi, BW Jibir, H Bello-Manga… - The Lancet …, 2022 - thelancet.com
Background In high-income countries, standard care for primary stroke prevention in
children with sickle cell anaemia and abnormal transcranial Doppler velocities results in a …

Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial

SU Abdullahi, BW Jibir… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background In high-income countries, standard care for primary stroke prevention in
children with sickle cell anaemia and abnormal transcranial Doppler velocities results in a …

[HTML][HTML] Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial

SU Abdullahi, BW Jibir, H Bello-Manga… - The Lancet …, 2022 - eprints.soton.ac.uk
Background: In high-income countries, standard care for primary stroke prevention in
children with sickle cell anaemia and abnormal transcranial Doppler velocities results in a …

Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial.

SU Abdullahi, BW Jibir, H Bello-Manga… - The Lancet …, 2022 - europepmc.org
Background In high-income countries, standard care for primary stroke prevention in
children with sickle cell anaemia and abnormal transcranial Doppler velocities results in a …

Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial

SU Abdullahi, BW Jibir, H Bello-Manga, S Gambo… - The Lancet …, 2022 - Elsevier
Background In high-income countries, standard care for primary stroke prevention in
children with sickle cell anaemia and abnormal transcranial Doppler velocities results in a …

Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial

SU Abdullahi, BW Jibir, H Bello-Manga… - The Lancet …, 2022 - discovery.ucl.ac.uk
Background: In high-income countries, standard care for primary stroke prevention in
children with sickle cell anaemia and abnormal transcranial Doppler velocities results in a …

[HTML][HTML] Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial

SU Abdullahi, BW Jibir, H Bello-Manga… - The Lancet …, 2022 - ncbi.nlm.nih.gov
Background In high-income countries, standard care for primary stroke prevention in
children with sickle cell anaemia and abnormal transcranial Doppler velocities results in a …